This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Sep;52(3):1174-5.

doi: 10.1002/hep.23741.

Treating fatty liver for the prevention of cardiovascular diseases

Federico Salamone, Fabio Galvano, Giovanni Li Volti

PMID: 20658467
DOI: 10.1002/hep.23741

Comment

Treating fatty liver for the prevention of cardiovascular diseases

Federico Salamone et al. Hepatology. 2010 Sep.

. 2010 Sep;52(3):1174-5.

doi: 10.1002/hep.23741.

Authors

Federico Salamone, Fabio Galvano, Giovanni Li Volti

PMID: 20658467
DOI: 10.1002/hep.23741

No abstract available

PubMed Disclaimer

Comment on

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.
Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O'Donnell CJ, Fox CS. Speliotes EK, et al. Hepatology. 2010 Jun;51(6):1979-87. doi: 10.1002/hep.23593. Hepatology. 2010. PMID: 20336705 Free PMC article.

Similar articles

[Non-alcoholic fatty liver disease and cardiovascular risk].
Abel T, Fehér J. Abel T, et al. Orv Hetil. 2008 Jul 13;149(28):1299-305. doi: 10.1556/OH.2008.28418. Orv Hetil. 2008. PMID: 18617457 Review. Hungarian.
[Role of fatty liver in metabolic syndrome].
Fodor M. Fodor M. Orv Hetil. 2010 Aug 29;151(35):1430-3. doi: 10.1556/OH.2010.28897. Orv Hetil. 2010. PMID: 20719718 Hungarian.
[Influence of non-alcoholic fatty liver disease on cardiovascular disease].
Ampuero J, Romero-Gómez M. Ampuero J, et al. Gastroenterol Hepatol. 2012 Oct;35(8):585-93. doi: 10.1016/j.gastrohep.2012.02.005. Epub 2012 Apr 26. Gastroenterol Hepatol. 2012. PMID: 22541252 Review. Spanish.
Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
den Boer M, Voshol PJ, Kuipers F, Havekes LM, Romijn JA. den Boer M, et al. Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):644-9. doi: 10.1161/01.ATV.0000116217.57583.6e. Epub 2004 Jan 8. Arterioscler Thromb Vasc Biol. 2004. PMID: 14715643 Review.
Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
Nestel PJ, Mensink RP. Nestel PJ, et al. Curr Opin Lipidol. 2013 Feb;24(1):1-3. doi: 10.1097/MOL.0b013e32835c0834. Curr Opin Lipidol. 2013. PMID: 23298957

See all similar articles

Cited by

Moro orange juice prevents fatty liver in mice.
Salamone F, Li Volti G, Titta L, Puzzo L, Barbagallo I, La Delia F, Zelber-Sagi S, Malaguarnera M, Pelicci PG, Giorgio M, Galvano F. Salamone F, et al. World J Gastroenterol. 2012 Aug 7;18(29):3862-8. doi: 10.3748/wjg.v18.i29.3862. World J Gastroenterol. 2012. PMID: 22876038 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley